These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2286141)

  • 1. Prevalence of vascular complications in untreated diabetics with obesity during an 18 year period.
    Okuno G; Ohki A; Kawakami F; Tako H
    Diabetes Res Clin Pract; 1990; 10 Suppl 1():S257-62. PubMed ID: 2286141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension in Diabetes Study (HDS): I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications.
    J Hypertens; 1993 Mar; 11(3):309-17. PubMed ID: 8387089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischemic heart disease in patients with diabetes mellitus in Japan.
    Takeda R; Shimizu M
    Diabetes Res Clin Pract; 1994 Oct; 24 Suppl():S199-203. PubMed ID: 7859605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Obesity and diabetes in the aged--correlation and relation to some chronic diseases].
    Weber P; Dedek I; Kocourková B
    Z Gerontol; 1993; 26(4):280-4. PubMed ID: 8212799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
    Fabian W; Majkowska L; Stefański A; Moleda P
    Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible role of insulin on the pathogenesis of macrovascular disease in human diabetics: clinical survey among 526 Japanese diabetic patients.
    Sato Y; Yamanouchi K; Sakamoto N
    Tohoku J Exp Med; 1983 Dec; 141 Suppl():529-33. PubMed ID: 6393438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factor analyses for macrovascular complication in nonobese NIDDM patients. Multiclinical Study for Diabetic Macroangiopathy (MSDM).
    Ito H; Harano Y; Suzuki M; Hattori Y; Takeuchi M; Inada H; Inoue J; Kawamori R; Murase T; Ouchi Y; Umeda F; Nawata H; Orimo H
    Diabetes; 1996 Jul; 45 Suppl 3():S19-23. PubMed ID: 8674883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevalence of dyslipidaemia, hypertension and vascular complications in newly diagnosed diabetics (prospective study: part 2)].
    Perusicová J
    Vnitr Lek; 2001 Mar; 47(3):146-50. PubMed ID: 15635875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of peripheral vascular disease in sulfonylurea treated diabetic patients with proteinuria.
    Migdalis IN; Kourti A; Voudouris G; Likoudi A; Samartzis M
    Int Angiol; 1990; 9(4):271-3. PubMed ID: 2099962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of diabetes and other cardiovascular risk factors in an Iranian population with acute coronary syndrome.
    Esteghamati A; Abbasi M; Nakhjavani M; Yousefizadeh A; Basa AP; Afshar H
    Cardiovasc Diabetol; 2006 Jul; 5():15. PubMed ID: 16842631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Complications and associated conditions in obese and non-obese diabetics].
    Jasný T
    Cesk Gastroenterol Vyz; 1969 Jan; 23(1):49-56. PubMed ID: 5780768
    [No Abstract]   [Full Text] [Related]  

  • 12. Maximum BMI and microvascular complications in a cohort of Japanese patients with type 2 diabetes: the Japan Diabetes Complications Study.
    Tanaka S; Tanaka S; Iimuro S; Ishibashi S; Yamashita H; Moriya T; Katayama S; Akanuma Y; Ohashi Y; Yamada N; Araki A; Ito H; Sone H;
    J Diabetes Complications; 2016 Jul; 30(5):790-7. PubMed ID: 26997170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity and hypertension in diabetic Nigerians.
    Akintewe TA; Adetuyibi A
    Trop Geogr Med; 1986 Jun; 38(2):146-9. PubMed ID: 3488608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pattern of diabetic complications in African patients in Dar es Salaam.
    Mhando PA; Yudkin JS
    Trop Geogr Med; 1980 Dec; 32(4):317-23. PubMed ID: 7210171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body fat mass distribution. Influence on metabolic and atherosclerotic parameters in non-insulin dependent diabetics and obese subjects with and without impaired glucose tolerance. Influence of weight reduction.
    Van Gaal L
    Verh K Acad Geneeskd Belg; 1989; 51(1):47-80. PubMed ID: 2800685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes mellitus and its vascular complications in Japanese migrants on the Island of Hawaii.
    Kawate R; Yamakido M; Nishimoto Y; Bennett PH; Hamman RF; Knowler WC
    Diabetes Care; 1979; 2(2):161-70. PubMed ID: 520120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overweight, obesity and chronic complications of diabetes mellitus in patients attending Diabetic Centre, Teaching Hospital, Jaffna, Sri Lanka.
    Sujanitha V; Sivansuthan S; Selvakaran P; Parameswaran P
    Ceylon Med J; 2015 Sep; 60(3):94-6. PubMed ID: 26520862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Polish Multicenter Study on Diabetes Epidemiology (PMSDE)--1998-2000].
    Szybiński Z
    Pol Arch Med Wewn; 2001 Sep; 106(3):751-8. PubMed ID: 11928582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for macrovascular disease in diabetes mellitus: the London follow-up to the WHO Multinational Study of Vascular Disease in Diabetics.
    Morrish NJ; Stevens LK; Fuller JH; Jarrett RJ; Keen H
    Diabetologia; 1991 Aug; 34(8):590-4. PubMed ID: 1936663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of adiponectin and inflammatory cytokines on diabetic vascular complications in obese and non-obese patients with type 2 diabetes mellitus.
    Hong SB; Lee JJ; Kim SH; Suh YJ; Han JY; Kim YS; Nam M
    Diabetes Res Clin Pract; 2016 Jan; 111():58-65. PubMed ID: 26589367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.